Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Viva Gold Reports Strong Initial Assay Results for its Fall 2024 Drill Program (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Science 37 Holdings Inc SNCE

Financial Services Technology Scientific & Technical Instruments
Science 37 Holdings, Inc. is engaged in patient-centric clinical trials and in supporting novel approaches to decentralized clinical trial designs. Through its patient-centric approach, it reduces the impact of the geographic barriers associated with conventional physical clinical trial sites, enabling recruitment of virtually any patient. Its offerings lie in its configurable unified... see more

Recent & Breaking News (NDAQ:SNCE)

Science 37 Nearly Doubles U.S. Enrollment for GSK Phase 3 Rare Disease Trial

GlobeNewswire November 21, 2024

Science 37 Earns Frost & Sullivan's 2024 Global Company of the Year Award for Decentralized Clinical Trials

GlobeNewswire September 16, 2024

Science 37 Unveils New Corporate Headquarters in Research Triangle Park, NC

GlobeNewswire August 6, 2024

Science 37 Enrolls 42% of Trial Cohort in 8 Weeks

GlobeNewswire July 18, 2024

Science 37 Quickly Impacts Performance in Under-Enrolling Clinical Trials

GlobeNewswire June 27, 2024

CORRECTION-- Science 37 Surpasses Enrollment Goals, Accelerates Phase 2 Rare Disease Clinical Trial

GlobeNewswire June 12, 2024

Science 37 Surpasses Enrollment Goals, Accelerates Phase 2 Rare Disease Clinical Trial

GlobeNewswire June 12, 2024

Science 37 Metasite(TM) Undergoes Successful FDA Inspection, Marking Major Milestone in Virtual Site Quality Assurance and Compliance

GlobeNewswire May 13, 2024

Science 37 Wins 2024 MedTech Breakthrough Award for "Clinical Efficiency Innovation"

GlobeNewswire May 9, 2024

Science 37 Delivers 22x Faster Enrollment than Traditional Methods in Phase 3 Asthma Clinical Trial

GlobeNewswire May 2, 2024

Science 37 Provides Fully Consented Patients to Sites to Supplement Enrollment

GlobeNewswire April 17, 2024

eMed completes tender offer for all outstanding shares of Science 37

PR Newswire March 12, 2024

SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates CHRD, TCN, SNCE

PR Newswire February 27, 2024

SCIENCE 37 HOLDINGS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Science 37 Holdings, Inc. - SNCE

Business Wire February 27, 2024

Kuehn Law Encourages DFS, SNCE, HRT, and IONM Investors to Contact Law Firm

PR Newswire February 19, 2024

SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates EVBG, BATL, JNPR, SNCE

Accesswire February 17, 2024

SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Continues Investigating the Merger - SNCE, BATL, AVRO

Accesswire February 16, 2024

SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates PGTI, AVRO, SNCE, JNPR

Accesswire February 16, 2024

SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Continues Investigating the Merger - PGTI, SNCE, JNPR

Accesswire February 15, 2024

SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates DOOR, EVBG, MGRC, SNCE

PR Newswire February 12, 2024